Merger and acquisition activities in China increased due to Covid-19
According to GlobalData's Medical Devices Deal Database, key M&A activities in China increased significantly from 2018 to 2021.
By
2022 So far In Venture Capital
Latest in
2022 So far In Venture Capital
Seegene signs Covid-19 tests supply deal with Brazil
The Allplex SARS-CoV-2/FluA/FluB/RSV PCR assay can detect influenza A and B, Covid-19, and RSV in a single test.
Suneva Medical signs merger with Viveon Health
Suneva develops, produces and markets new products for the regenerative medical aesthetic market.
WHO and MPP enter worldwide licencing deal for Covid-19 antibody test
All associated patents and biological material needed for the test's production are included in the deal.
LumiraDx completes merger with CA Health Acquisition
LumiraDx has ten new tests awaiting approvals over the next two years as well as five already approved assays.
Covid-19 testing firm Prenetics agrees to go public with SPAC merger
The company will use the merger proceeds to support continued growth and geographic expansion.
LumiraDx and CA Healthcare Acquisition revise merger agreement
On closing the deal, current LumiraDx stakeholders will retain the entirety of their present holdings in the company.
Memic agrees to merge with MedTech Acquisition
The combined firm will operate as Memic on concluding the deal, with an expected pro-forma equity value of more than…